{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:39:39Z","timestamp":1791841179405,"version":"4.3.4"},"reference-count":21,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Healthcare workers (HCWs) are at an elevated risk of contracting COVID-19. While intense occupational exposure associated with aerosol-generating procedures underlines the necessity of using personal protective equipment (PPE) by HCWs, high-transmission efficiency of the causative agent [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] could also lead to infections beyond such settings. Hydroxychloroquine (HCQ), a repurposed antimalarial drug, was empirically recommended as prophylaxis by the National COVID-19 Task Force in India to cover such added risk. Against this background, the current investigation was carried out to identify the factors associated with SARS-CoV-2 infection among HCWs in the country.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A case-control design was adopted and participants were randomly drawn from the countrywide COVID-19 testing data portal maintained by the ICMR. The test results and contact details of HCWs, diagnosed as positive (cases) or negative (controls) for SARS-CoV-2 using real-time reverse transcription-polymerase chain reaction (qRT-PCR), were available from this database. A 20-item brief-questionnaire elicited information on place of work, procedures conducted and use of PPE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Compared to controls, cases were slightly older (34.7 vs. 33.5 yr) and had more males (58 vs. 50%). In multivariate analyses, HCWs performing endotracheal intubation had higher odds of being SARS-CoV-2 infected [adjusted odds ratio (AOR): 4.33, 95% confidence interval (CI): 1.16-16.07]. Consumption of four or more maintenance doses of HCQ was associated with a significant decline in the odds of getting infected (AOR: 0.44; 95% CI: 0.22-0.88); a dose-response relationship existed between frequency of exposure to HCQ and such reductions (\u03c7<jats:sup>2<\/jats:sup> for trend=48.88; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). In addition, the use of PPE was independently associated with the reduction in odds of getting infected with SARS-CoV-2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretations &amp; conclusions:<\/jats:title>\n            <jats:p>Until results of clinical trials for HCQ prophylaxis become available, this study provides actionable information for policymakers to protect HCWs at the forefront of COVID-19 response. The public health message of sustained intake of HCQ prophylaxis as well as appropriate PPE use need to be considered in conjunction with risk homoeostasis operating at individual levels.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_2234_20","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T08:02:01Z","timestamp":1590912121000},"page":"459-467","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":164,"title":["Healthcare workers &amp; SARS-CoV-2 infection in India"],"prefix":"10.25259","volume":"151","author":[{"given":"Pranab","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanu","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kh. Jitenkumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"Rasaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santasabuj","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman R.","family":"Gangakhedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-11-20241212","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3201\/eid2606.200239","article-title":"Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020","volume":"26","author":"Liu","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R2-11-20241212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"R3-11-20241212","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"R4-11-20241212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/ijmr.IJMR_519_20","article-title":"The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence","volume":"151","author":"Chatterjee","year":"2020","journal-title":"Indian J Med Res"},{"key":"R5-11-20241212","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.006","article-title":"Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study","volume":"80","author":"Huang","year":"2020","journal-title":"J Infect"},{"key":"R11-11-20241212","first-page":"CD011621","article-title":"Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff","volume":"4","author":"Verbeek","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-11-20241212","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"R14-11-20241212","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"R15-11-20241212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18683\/germs.2019.1155","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): A review","volume":"9","author":"Ramadan","year":"2019","journal-title":"Germs"},{"key":"R17-11-20241212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"R18-11-20241212","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"R19-11-20241212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"R23-11-20241212","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2307\/2531743","article-title":"Power calculations for matched case-control studies","volume":"44","author":"Dupont","year":"1988","journal-title":"Biometrics"},{"key":"R25-11-20241212","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"R26-11-20241212","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10393-016-1100-5","article-title":"Lessons from the Ebola outbreak: Action items for emerging infectious disease preparedness and response","volume":"13","author":"Jacobsen","year":"2016","journal-title":"Ecohealth"},{"key":"R27-11-20241212","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/infdis\/jiy612","article-title":"Outbreak investigation of Nipah virus disease in Kerala, India, 2018","volume":"219","author":"Arunkumar","year":"2019","journal-title":"J Infect Dis"},{"key":"R29-11-20241212","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"R31-11-20241212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"R32-11-20241212","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/S2214-109X(20)30114-5","article-title":"Use of antiviral drugs to reduce COVID-19 transmission","volume":"8","author":"Mitj\u00e0","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R35-11-20241212","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S2468-2667(20)30060-8","article-title":"The resilience of the Spanish health system against the COVID-19 pandemic","volume":"5","author":"Legido-Quigley","year":"2020","journal-title":"Lancet Public Health"},{"key":"R36-11-20241212","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(99)09109-6","article-title":"Condoms and seat belts: The parallels and the lessons","volume":"355","author":"Richens","year":"2000","journal-title":"Lancet"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_2234_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:03:13Z","timestamp":1751497393000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/healthcare-workers-sars-cov-2-infection-in-india-a-case-control-investigation-in-the-time-of-covid-19\/"}},"subtitle":["A case-control investigation in the time of COVID-19"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_2234_20","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}